Robert Koch

Koch studied medicine at Göttingen from 1862 to 1866, where the anatomist Jacob Henle had long argued that living agents might cause contagious diseases. After hospital and general-practice posts and medical service in the Franco-Prussian War, Koch became district medical officer in 1872 at Wollstein in the Prussian province of Posen. The town is now Wolsztyn in Poland; giving both names avoids treating the shifting political geography as timelessly German.⁸

Anthrax—then also called Milzbrand, splenic fever, or charbon— was an economically important disease of grazing animals that could also infect people working with animals or their products. Koch improvised a laboratory in his home and cultured material in hanging drops of ox aqueous humour kept warm on a microscope stage. In 1876 he demonstrated the work to botanist Ferdinand Cohn and pathologists Julius Cohnheim and Carl Weigert in Breslau (now Wrocław, Poland); Cohn then published it in his botanical journal.³

That sequence matters. Koch did not first observe the anthrax bacillus, nor was microbial causation an idea without predecessors. His experiments joined previous observations to a visible developmental cycle, transmission in animals, and a material account of environmental persistence. Recognition also depended on Cohn’s authority and on a scientific network able to assess, print, and circulate a provincial doctor’s work.

In 1880 Koch joined the Imperial Health Office in Berlin. There he had rooms, instruments, animals, assistants, and official responsibilities that transformed the scale of his work. A transparent solid medium allowed a dispersed microbial cell to form a visible colony separated from its neighbours. This “pure culture” ideal made it easier to compare organisms, repeat experiments, and train investigators in a common routine. ¹

The material history corrects the image of Koch as sole inventor. He first used sliced potatoes and gelatin. Gelatin melted in warm conditions and some microbes digested it. In 1881 Fanny Hesse suggested agar, a seaweed-derived jellying material she knew through domestic food practice, to her husband Walther, who was working with Koch. The Hesses did not publish a priority paper, and surviving documentation is incomplete, but contemporary textbooks recorded their contribution. Petri’s covered dish followed later. ⁴

The “Koch school” also included Friedrich Löffler, Georg Gaffky, Paul Ehrlich, Emil von Behring, and Shibasaburō Kitasato, among others. Their careers were not simply extensions of Koch’s. They developed distinct work on diphtheria, typhoid, staining, immunity, serum therapy, and tetanus. The laboratory’s authority therefore rested on coordinated labour, instruments, animals, state salaries, and publication as much as on its director. ¹

Before Koch, “consumption” or phthisis was interpreted through heredity, constitution, environment, inflammation, and contagion in varying combinations. René Laennec had argued that several lesions belonged to one tuberculous process, and in 1865 Jean-Antoine Villemin transmitted disease to rabbits with tuberculous material. Koch entered an active debate; he did not originate the suspicion that tuberculosis was communicable. ⁶

Koch’s 1882 lecture to the Berlin Physiological Society brought different forms of evidence together. He reported the bacillus in tuberculous tissue, described a new alkaline methylene-blue stain, cultivated the slow-growing organism on coagulated blood serum, and produced tuberculosis in several animal species with cultured material. His published paper was written to establish bacterial aetiology and to persuade specialist readers; it is a primary account of his argument, not a neutral record of every predecessor, assistant, patient, or failed experiment.⁵

The paper changed the classification and investigation of disease more immediately than it changed patients’ prospects. It supplied neither a cure nor a vaccine. Laboratory identification could support diagnosis and public health, but tuberculosis also followed housing, nutrition, work, exposure, and susceptibility. Later medicine retained the bacterial cause while rejecting the notion that naming a pathogen by itself explained why every exposed person did or did not become ill.⁷

In 1883 the German government sent a commission led by Koch to investigate cholera in Alexandria. As the Egyptian epidemic subsided, the group moved to Calcutta (now Kolkata) in British India. Koch associated a curved “comma” bacillus with cholera intestines and stools, cultivated it, and connected transmission to contaminated water. The expedition joined laboratory method to imperial mobility and international sanitary politics. ⁹

Koch should not be called the first discoverer of the cholera vibrio. Florentine anatomist Filippo Pacini had described the organism in 1854 and argued for its causal role, while John Snow used mortality and water-supply evidence in London that same year without isolating a pathogen. Pacini’s work gained little recognition at the time; Koch’s better-resourced commission, culture methods, and existing reputation made the bacteriological claim far more influential.⁹

Cholera also exposed the limits of any rigid postulate story. Koch could not reproduce the human disease convincingly in experimental animals, yet he regarded the repeated pathological, bacteriological, and epidemiological evidence as sufficient. Environmental and public-health arguments did not disappear when the vibrio was accepted: water, sanitation, poverty, and political administration remained essential to explaining who was exposed. ⁷

At the Tenth International Medical Congress in Berlin in August 1890, Koch announced that an undisclosed substance could halt tuberculosis in guinea pigs. He soon presented it as a treatment for some forms of human disease. Doctors and patients travelled to Berlin, but Koch initially withheld the preparation’s composition, prior testing, and proposed mechanism. The authority earned in 1882 substituted for information that independent investigators needed.⁶

The material, later named tuberculin, was an extract of tubercle-bacillus cultures. Early use produced intense systemic reactions; clinicians reported deterioration and deaths, and Rudolf Virchow’s post-mortem observations undermined Koch’s belief that tissue necrosis would starve the bacilli. By 1891 the curative claim had collapsed. This was more than an unfortunate negative trial: secrecy, short follow-up, public promotion, and inadequate clinical evidence magnified the harm.⁶

Tuberculin’s later diagnostic use should not be read back as vindication of the original cure. Later investigators repurposed tuberculin reactions to detect prior immune sensitisation, with methods and meanings different from Koch’s therapeutic claim. The episode is a central part of his history because it shows that a powerful causal programme did not automatically yield safe therapy.⁶

Koch became the first professor of hygiene at Berlin’s Friedrich-Wilhelms-Universität in 1885 and in 1891 director of the new Royal Prussian Institute for Infectious Diseases. The institute combined research, clinical wards, training, and advice to government. It helped make the laboratory a permanent part of public administration rather than a temporary annex to an individual investigator’s career.⁸

From the mid-1890s Koch repeatedly travelled to investigate animal and human diseases in southern Africa, India, East Africa, Italy, Java, and New Guinea. These journeys generated observations on malaria, plague, cattle diseases, and asymptomatic infection, but they were made through imperial governments that controlled movement, labour, land, and access to patients. “Tropical medicine” was not a neutral geographic category: it developed inside projects for administering colonies and protecting military and economic interests. ^{8 10}

The clearest ethical failure came during Koch’s 1906–1907 sleeping-sickness mission. After stops in German East Africa, his team worked on the Sese Islands of Lake Victoria in British-ruled Uganda. Koch experimented on African patients with arsenic compounds, especially atoxyl. It temporarily reduced parasites in the blood but could cause severe pain, optic-nerve damage, and blindness; Koch increased doses despite knowing the risks. He also advocated isolating infected people in camps. Colonial power made such experiments and proposed confinement possible on terms African patients did not control.^{10 11}

Koch’s strongest legacy is a style of proof: locate an organism, distinguish it materially from others, connect it repeatedly with disease, and test the causal claim. That programme made laboratory diagnosis, microbial taxonomy, and state bacteriological institutes central to medicine. It also provided a model that students and collaborators revised rather than simply inherited. ^{1 7}

The familiar title “father of bacteriology” is too blunt. Microscopy and germ theories preceded Koch; anthrax and cholera research had named contributors before him; culture technology was collective; and Louis Pasteur led a rival French programme. Priority is best stated disease by disease and method by method, not awarded wholesale to one national hero. ¹

Nor did disease specificity end epidemiological complexity. In later work Koch himself became more attentive to infection without symptoms and to carriers, evidence that a pathogen-centred programme had to accommodate host response and transmission. Historians therefore document both the precision Koch brought to causal evidence and the reductionism, therapeutic overreach, and imperial coercion that accompanied his authority. ¹²